The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin

Journal of Clinical Investigation

Volumn 104, Issue 2, 1999, Pages 147-153

  Greiner, Bernd ^a,b,d   Eichelbaum, Michel ^a,b   Fritz, Peter ^c   Kreichgauer, Hans Peter ^c   Von Richter, Oliver ^a   Zundler, Johannes ^c   Kroemer, Heyo K ^a,e  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ROBERT BOSCH HOSPITAL   (Germany)

^d MERCK KGAA   (Germany)

^e UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; DIGOXIN; GLYCOPROTEIN P; RIFAMPICIN; VILLIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOLECULAR INTERACTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN INTERACTION; QUANTITATIVE DIAGNOSIS;

EID: 0032754284     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6663     Document Type: Article

References (39)

1. Fromm, M.F., Busse, D., Kroemer, H.K., and Eichelbaum, M. 1996. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin. Hepatology. 24:796-801.
2. Krishna, D.R., and Klotz, U. 1994. Extrahepatic metabolism of drugs in humans. Clin. Pharmacokinet. 26:144-160.
3. Gault, H., Longerich, L., Dawe, M., and Fine, A. 1984. Digoxinrifampin interaction. Clin. Pharmacol. Ther. 35:750-754.
4. Novi, C., et al. 1980. Rifampin and digoxin: possible drug interaction in a dialysis patient. JAMA. 244:2521-2522.
5. Hinderling, P.H., and Hartmann, D. 1991 Pharmacokinetics of digoxin and main metabolites/ derivatives in healthy humans. Ther. Drug Monit. 13:381-401.
6. Lacarelle, B., et al. 1991. Metabolism of digoxin, digoxigenin, digitoxosides and digoxigenin in human hepatocytes and liver microsomes. Fundam. Clin. Pharmacol. 5:567-582.
7. Ito, S., Koren, G., and Harper, P.A. 1992. Energy-dependent transport of digoxin across renal tubular cell monolayers (LLC-PK1). Can. J. Physiol. Pharmacol. 71:40-47.
8. Ito, S., Woodland, C., Harper, P.A., and Koren, G. 1993. P-glycoprotein-mediated renal tubular secretion of digoxin: the toxicological significance of the urine-blood barrier model. Life Sci. 53:PL25-PL31.
9. de Lannoy, I.A.M., and Silverman, M. 1992. The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem. Biophys. Res. Commun. 189:551-557.
10. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A.A.M., and Borst, P. 1995. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. J. Clin. Invest. 96:1698-1705.
11. Gatmaitan, Z.C., and Arias, I.M. 1993. Structure and function of P-glycoprotein in normal liver and small intestine. Adv. Pharmacol. 24:77-97.
12. Fromm, M.F., Kim, R.B., Stein, C.M., Wilkinson, G.R., and Roden, D.M. 1998. Inhibition of P-glycoprotein-mediated drug transport. Circulation. 99:552-557.
13. Kim, R.B., et al. 1997. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Invest. 101:289-294.
14. Mayer, U., et al. 1996. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein. Br J. Pharmacol. 119:1038-1044.
15. Cordon-Cardo, C., et al. 1990. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J. Histochem. Cytochem. 38:1277-1287.
16. Thiebaut, F., et al. 1987. Cellular localization of the multidrug resistance gene product in normal human tissues. Proc. Natl. Acad. Sci. USA. 84:7735-7738.
17. Terao, T., Hisanaga, E., Sai, Y., Tamai, I., and Tsuji, A. 1996. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J. Pharm. Pharmacol. 48:1083-1089.
18. Mayer, U., et al. 1997. Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J. Clin. Invest. 100:2430-2436.
19. Schuetz, E.G., Beck, W.T., and Schuetz, J.D. 1996. Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:311-318.
20. Guengerich, F.P., et al. 1986. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genomic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261:5051-5060.
21. Hsu, S.M., Raine, L., and Fanger, H. 1981. The use of anti-avidin antibody and avidin-biotin-complex in immunoperoxidase techniques. Am. J. Clin. Pathol. 75:816-821.
22. Fritz, P., Behrle, E., Beaune, P., Eichelbaum, M., and Kroemer, H.K. 1993. Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P 450 3A and glutathione-S-transferase. Histochemistry. 99:443-451.
23. Chu, T.M., Kawinski, E., and Lin, T.H. 1993. Characterization of a new monoclonal antibody F4 detecting cell surface epitope and P-glycoprotein in drug-resistant human tumor cell lines. Hybridoma. 12:417-429.
24. Sternberger, L.A., Hardy, P.H., Cuculis J.J., and Meyer, H.G. 1970. The unlabeled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochaetes. J. Histochem. Cytochem. 18:315-334.
25. Fritz, P., et al. 1992. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients. J. Histochem. Cytochem. 26:146-158.
26. Smith, P.K., et al. 1985. Measurment of protein using bichinonic acid. Anal. Biochem. 150:76-85.
27. Kolars, J.C., Schmiedlin-Ren, P., Schuetz, J.D., Fang, C., and Watkins, P.B. 1992. Identification of rifampicin-inducible P450IIIA4 (Cyp3A4) in human small bowel enterocytes. J. Clin. Invest. 90:1871-1878.
28. Sparreboom, A., et al. 1997. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA. 94:2031-2035.
29. Lown, K.S., et al. 1997. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporin. Clin. Pharmacol. Ther. 62:248-260.
30. de Lannoy, I.A.M., Koren, G., Klein, J., Charuk, J., and Silverman, M. 1992. Cyclosporine and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin. Am. J. Physiol 263:F613-F622.
31. Okamura, N., et al. 1993. Digoxin-cyclosporin A interaction: modulation of the multidrug transporter P-glycoprotein in the kidney. J. Pharmacol. Exp. Ther. 266:1614-1619.
32. Su, S.F., and Huang, J.D. 1995. Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metab. Dispos. 24:142-147.
33. Hori, R., Okamura, N., Aiba, T., and Tanigawara, Y. 1993. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney. J. Pharmacol. Exp. Ther. 266:1620-1625.
34. Ito, S., Woodland, C., Harper, P.A., and Koren, G. 1993. The mechanism of the verapamil-digoxin interaction in renal tubular cells (LLC-PK1). Life Sci. 53:PL399-PL403.
35. Calvo, M.V., et al. 1989. Interaction between digoxin and propafenone. Ther. Drug Monit. 11:10-15.
36. Jalava, K.M., Partanen, J., and Neuvonen, P.J. 1997. Itraconazole decreases renal clearance of digoxin. Ther. Drug Monit. 19:609-613.
37. Calleja, C., Pascussi, J.M., Mani, J.C., Maurel, P., and Vilarem, M.J. 1998. The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nat Med. 4:92-96.
38. Henriksson, G., Norlander, T., Zheng, X., Stierna, P., and Westrin, K.M. 1997. Expression of P-glycoprotein 170 in nasal mucosa may be increased with topical steroids. Am. J. Rhinol. 11:317-321.
39. Zhao, J.Y., Ikeguchi, M., Eckersberg, T., and Kuo, M.T. 1993. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells. Endocrinology. 133:521-528.